Works by Kim, Nahyun

Results: 81
    1
    2

    Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis.

    Published in:
    Osteoporosis International, 2024, v. 35, n. 11, p. 1919, doi. 10.1007/s00198-024-07161-x
    By:
    • Reginster, Jean-Yves;
    • Czerwinski, Edward;
    • Wilk, Krzysztof;
    • Borowy, Przemysław;
    • Strzelecka, Anna;
    • Budlewski, Tomasz;
    • Janowska-Maus, Monika;
    • Szymanowski, Krzysztof;
    • Kwiatek, Joanna;
    • Postol, Svitlana;
    • Põder, Airi;
    • Supronik, Jerzy;
    • Kim, SungHyun;
    • Suh, JeeHye;
    • Han, NooRi;
    • Kim, NaHyun;
    • Bae, SeoHee;
    • Silverman, Stuart L.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss.

    Published in:
    Experimental & Molecular Medicine EMM, 2021, v. 53, n. 7, p. 1192, doi. 10.1038/s12276-021-00653-4
    By:
    • Lee, Sang-Yeon;
    • Choi, Hyun Been;
    • Park, Mina;
    • Choi, Il Soon;
    • An, Jieun;
    • Kim, Ami;
    • Kim, Eunku;
    • Kim, Nahyun;
    • Han, Jin Hee;
    • Kim, Min young;
    • Lee, Seung min;
    • Oh, Doo-Yi;
    • Kim, Bong Jik;
    • Yi, Nayoung;
    • Kim, Nayoung, K. D.;
    • Lee, Chung;
    • Park, Woong-Yang;
    • Koh, Young Ik;
    • Gee, Heon Yung;
    • Cho, Hyun Sung
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.

    Published in:
    Expert Opinion on Biological Therapy, 2024, v. 24, n. 4, p. 305, doi. 10.1080/14712598.2024.2334386
    By:
    • Park, Min Ho;
    • Seo, Jae Hong;
    • Park, Jung Ho;
    • Seong, Min-Ki;
    • Park, Keon Uk;
    • Kim, Min Kyoon;
    • Chang, Myungchul;
    • Koh, Su-Jin;
    • Lee, Moon Hee;
    • Lim, Seung Taek;
    • Yoo, Young Bum;
    • Oh, So Yeon;
    • Kim, Sung Hyun;
    • Ahn, Keum Young;
    • Park, Tae Hong;
    • Ju, Hana;
    • Baek, Eric Hyungseok;
    • Kim, Sinhye;
    • Kim, Nahyun;
    • Lee, Eunkyung
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41

    Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial.

    Published in:
    BioDrugs, 2023, v. 37, n. 3, p. 433, doi. 10.1007/s40259-023-00582-w
    By:
    • Stebbing, Justin;
    • Baranau, Yauheni;
    • Baryash, Valery;
    • Moiseyenko, Vladimir;
    • Boliukh, Dmytro;
    • Antone, Nicoleta;
    • Manikhas, Alexey;
    • Chornobai, Anatolii;
    • Park, Taehong;
    • Baek, Eric Hyungseok;
    • Lee, Jaeyong;
    • Choi, Jiin;
    • Kim, Nahyun;
    • Ahn, Keumyoung;
    • Lee, Sang Joon;
    • Kim, Sunghyun
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50